132P Genomic determinants of leukocyte homeostasis predict responses to immune checkpoint blockade (ICB) monotherapy versus combination therapy in patients (pts) with cancer.
Saved in:
| Title: | 132P Genomic determinants of leukocyte homeostasis predict responses to immune checkpoint blockade (ICB) monotherapy versus combination therapy in patients (pts) with cancer. |
|---|---|
| Authors: | Saleh, M.1 (AUTHOR), Saad, E.1 (AUTHOR), Machaalani, M.1 (AUTHOR), Ascione, L.1 (AUTHOR), Moura Barrios, P.1 (AUTHOR), El Masri, J.1 (AUTHOR), Daoud Khatoun, W.1 (AUTHOR), Nawfal, R.1 (AUTHOR), Eid, M.1 (AUTHOR), El Hajj Chehade, R.1 (AUTHOR), Semaan, K.1 (AUTHOR), Steiner, C.1 (AUTHOR), Yekeduz, E.1 (AUTHOR), Labaki, C.2 (AUTHOR), Saliby, R.M.3 (AUTHOR), El Zarif, T.3 (AUTHOR), Gusev, A.4 (AUTHOR), Choueiri, T.K.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS256-S257. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
